Developmental aspects of cortical excitability and inhibition in depressed and healthy youth: an exploratory study by Paul E. Croarkin et al.
ORIGINAL RESEARCH ARTICLE
published: 02 September 2014
doi: 10.3389/fnhum.2014.00669
Developmental aspects of cortical excitability and inhibition
in depressed and healthy youth: an exploratory study
Paul E. Croarkin1*, Paul A. Nakonezny2,3, Charles P. Lewis1, Michael J. Zaccariello1, John E. Huxsahl1,
Mustafa M. Husain4, Betsy D. Kennard3, Graham J. Emslie3 and Zafiris J. Daskalakis5
1 Division of Child and Adolescent Psychiatry, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA
2 Division of Biostatistics, Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, USA
3 Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA
4 Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA
5 Department of Psychiatry, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada
Edited by:
Lindsay M. Oberman, E.P. Bradley
Hospital and Warren Alpert Medical
School of Brown University, USA
Reviewed by:
Sudha Kilaru Kessler, University of
Pennsylvania School of Medicine,
USA
Motoaki Nakamura, Kanagawa
Psychiatric Center, Japan
*Correspondence:
Paul E. Croarkin, Department of
Psychiatry and Psychology, Mayo
Clinic, 200 First Street SW,
Generose, Rochester, MN 55905,
USA
e-mail: croarkin.paul@mayo.edu
Objectives: The objective of this post-hoc exploratory analysis was to examine the
relationship between age and measures of cortical excitability and inhibition.
Methods: Forty-six participants (24 with major depressive disorder and 22 healthy
controls) completed MT, SICI, ICF, and CSP testing in a cross-sectional protocol. Of these
46 participants, 33 completed LICI testing. Multiple linear robust regression and Spearman
partial correlation coefficient were used to examine the relationship between age and the
TMS measures.
Results: In the overall sample of 46 participants, age had a significant negative relationship
with motor threshold (MT) in both the right (rs = −0.49, adjusted p = 0.007; β = −0.08,
adjusted p = 0.001) and left (rs = −0.42, adjusted p = 0.029; β = −0.05, adjusted
p = 0.004) hemispheres. This significant negative relationship of age with MT was also
observed in the sample of depressed youth in both the right (rs = −0.70, adjusted
p = 0.002; β = −0.09, adjusted p = 0.001) and left (rs = −0.54, adjusted p = 0.034;
β = −0.05, adjusted p = 0.017) hemispheres, but not in healthy controls. In the sample of
the 33 participants who completed LICI testing, age had a significant negative relationship
with LICI (200ms interval) in both the right (rs = −0.48, adjusted p = 0.05; β = −0.24,
adjusted p = 0.007) and left (rs = −0.64, adjusted p = 0.002; β = −0.23, adjusted
p = 0.001) hemispheres. This negative relationship between age and LICI (200ms interval)
was also observed in depressed youth in both the right (rs = −0.76, adjusted p = 0.034;
β = −0.35, adjusted p = 0.004) and left (rs = −0.92, adjusted p = 0.002; β = −0.25,
adjusted p = 0.001) hemispheres.
Conclusion: These findings suggest that younger children have higher MTs. This is more
pronounced in depressed youth than healthy controls. LICI inhibition may also increase
with age in youth.
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INTRODUCTION
Transcranial magnetic stimulation (TMS) measures of cortical
excitability and inhibition have shown initial promise as biomark-
ers and for the study of neurophysiology in youth with attention
deficit hyperactivity disorder (Gilbert et al., 2011), neurodevelop-
mental disorders (Garvey et al., 2001, 2003; Garvey and Gilbert,
2004; Enticott et al., 2013; Oberman et al., 2013) andmood disor-
ders (Croarkin et al., 2013, 2014). These TMS paradigms involve
quantifying the effects of brief TMS pulses on the motor cortex
through the measurement of a motor evoked potential (MEP)
with surface electromyography (EMG) applied to hand muscles
such as the abductor pollicis brevis (APB) (Levin et al., 2014). The
amplitude of a MEP reflects the excitatory/inhibitory balance of
cortical pyramidal cells. Based on prior work, these measures have
good reliability and validity (Farzan et al., 2010). Notably, many
of these measures are indirect indices gamma-aminobutyric acid
(GABA) and glutamate receptor mediated neurotransmission
(Radhu et al., 2013).
Two measures of cortical excitability are the motor thresh-
old (MT) which is a single pulse TMS measure and intracor-
tical facilitation (ICF) which is a paired-pulse TMS measure.
Prior human pharmacologic studies indicate that the MT is
at least partially dependent on voltage-gated sodium channels
while ICF is an indirect measure of glutamatergic N-methyl-D-
aspartate (NMDA) mediated neurotransmission (Ziemann et al.,
1996a,b, 1998). The MT is operationally defined as the stimu-
lus intensity which produces a reliable MEP with a stimulation
intensity of at least 50 microvolts in 5 out of 10 trials. During
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ICF measures, a subthreshold condition stimulation (set to 80%
of resting MT) precedes a suprathreshold test stimulation with
interstimulus intervals of 10–20ms. The conditioned MEP is
compared to the MEP produced by a suprathreshold test stim-
ulus to examine the degree of change in amplitude. Higher ratios
reflect increased cortical facilitation. Measures of cortical inhibi-
tion include short-interval intracortical inhibition (SICI) (Kujirai
et al., 1993), long-interval cortical inhibition (LICI) (Daskalakis
et al., 2008; Farzan et al., 2010), and the cortical silent period
(CSP) (Garvey and Mall, 2008). Prior research suggests that SICI
is a measure of GABAA receptor mediated neurotransmission
(Kujirai et al., 1993; Paulus et al., 2008), while LICI and CSP
index GABAB receptor mediated neurotransmission (Connors
et al., 1988; Kujirai et al., 1993; McDonnell et al., 2006). For
SICI measures, a subthreshold conditioning stimulation (set to
80% of resting MT) precedes a suprathreshold test stimulation
with interstimulus intervals of 1–5ms. The conditioned MEP is
compared to the MEP produced by a suprathreshold test stim-
ulus to examine the degree of change in amplitude. Lower SICI
ratios reflect increased cortical inhibition. During LICI mea-
surements, suprathreshold conditioning and suprathreshold test
stimulations are applied to the motor cortex with 50–200ms
interstimulus intervals (Kujirai et al., 1993; Garvey and Mall,
2008). The conditioned MEP is compared to the MEP produced
by a suprathreshold test stimulus to examine the degree of change
in amplitude. Lower LICI ratios reflect increased cortical inhibi-
tion. During CSP testing the participant contracts the muscle of
interest submaximally while a suprathreshold, single-pulse stim-
ulation is administered to the motor cortex. The resultant period
of EMG silence corresponds to the amount of cortical inhibi-
tion (Farzan et al., 2013). Contralateral silent period measures
are typically collected in psychiatric research, although it is pos-
sible to collect ipsilateral silent period data as well (Garvey and
Gilbert, 2004). Both CSP measures reflect the function of cortical
inhibitory interneurons and the corpus callosum (Müller et al.,
1997; Garvey et al., 2003).
These neurophysiologic indices have potential for classify-
ing psychiatric illnesses and guiding pharmacologic treatments
(Ziemann, 2004; Paulus et al., 2008). Research regarding the
developmental courses of cortical excitability and inhibition mea-
sures in adulthood is emerging (McGinley et al., 2010; Fling and
Seidler, 2012; Heise et al., 2013; Levin et al., 2014; Liguz-Lecznar
et al., 2014), but remarkably little is known about the early trajec-
tory of each measure in health and disease (Moll et al., 1999; Mall
et al., 2004; Garvey, 2008). Although there is a paucity of research,
it is generally accepted that MT measures are higher in children
than in adults (Garvey and Gilbert, 2004; Garvey, 2008). At some
point in adolescence, MT values fall to adult levels (Garvey and
Gilbert, 2004). Some TMS studies suggest that the CSP dura-
tions increase with age while other studies others do not (Moll
et al., 1999; Garvey et al., 2003). Research regarding early age-
related differences in SICI and ICF is also inconclusive (Moll et al.,
1999; Garvey et al., 2003; Mall et al., 2004; Gilbert et al., 2011).
Further, there are few published reports examining LICImeasures
in children and adolescents (Croarkin et al., 2014). An enhanced
understanding of developmental changes in these neurophysio-
logic measures would have great utility. This knowledge would
advance understanding of neurodevelopment, the ontogeny of
GABA and glutamate neurotransmission, and inform neurophys-
iologic study protocols (Paulus et al., 2008; Radhu et al., 2013).
The aim of this exploratory study was to examine the current
suppositions regarding developmental changes in motor cortex
excitability and inhibition in early life. In particular, we exam-
ined the association of age with cortical inhibition (SICI, LICI,
and CSP) and excitability (MT, ICF).
METHODS
STUDY DESIGN AND OVERVIEW
This was a cross-sectional study of depressed youth and healthy
controls. All participants had a clinical evaluation and TMS test-
ing. Cortical inhibition (SICI, CSP) and excitability (MT and
ICF) were collected during a single session. A subgroup of this
cohort completed LICI testing during the same testing session.
Study design details have been previously published (Croarkin
et al., 2013, 2014). All study procedures were approved by the
local institutional review board prior to the enrollment of sub-
jects. Below is a brief description of relevant design aspects of this
study.
STUDY PARTICIPANTS
This study involved the 46 male and female, children and ado-
lescents, aged 9–17 years from our parent study (Croarkin et al.,
2013, 2014). In particular, 24 participants had major depres-
sive disorder (MDD) and 22 participants were healthy controls.
Of the 46 youth in our parent study (Croarkin et al., 2013,
2014), 33 of these participants (14 with MDD and 19 healthy
controls) completed the LICI testing protocol. This sample was
recruited from a pediatric mood disorders clinic and local adver-
tising. After obtaining written assent from youth and informed
consent from legal guardians, participants, and families were
evaluated by a board-certified child and adolescent psychia-
trist (P.E.C.). This included a clinical history, psychiatric history,
medical history, mental status exam, neurological exam, phys-
ical exam, urine pregnancy test for females who had reached
menarche, and a semi-structured interview with Schedule for
Affective Disorders and Schizophrenia, Present and Lifetime
Version (K-SADS-PL) (Kaufman et al., 1997). Depression severity
was assessed with the Children’s Depression Rating Scale, Revised
(CDRS-R) (Poznanski et al., 1983). The Oldfield’s Edinburgh
Handedness Inventory (Oldfield, 1971) was completed to con-
firm handedness. The TMS Adult Safety Screen (Keel et al., 2001)
was used to confirm safety for single- and paired-pulse TMS
testing. Depressed patients and healthy controls were not taking
psychotropic medications or receiving psychotherapy prior to the
TMS testing session.
A personal or family history of seizure disorders was
exclusionary. A prior history of neurosurgery was exclu-
sionary. Exclusionary psychiatric disorders in depressed
participants included autism spectrum disorders, bipolar
disorder, conduct disorder, eating disorders, mental retardation,
obsessive-compulsive disorder, posttraumatic stress disorder,
schizophrenia, substance use disorders, and tic disorders.
Screening for mental retardation involved a detailed review
of records and questions regarding academic performance. If
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below-average cognitive ability was considered, formal intellec-
tual screening was completed with the Kaufman Brief Intelligence
Test-2 (Kaufman and Kaufman, 2004). This encompassed verbal
knowledge, matrices, and riddles. Youth with an estimated IQ
less than 80 were not enrolled. Healthy control participants were
in excellent health and did not meet present or past diagnostic
criteria for any psychiatric illness based on the evaluation and the
K-SADS-PL interview.
PROCEDURES AND MEASURES
TMS testing
Cortical excitability and inhibition TMS testing was performed as
described in prior literature (Kujirai et al., 1993; Ziemann, 2004;
Paulus et al., 2008). Participants were seated and wore a swim cap
during the procedures. Participants and study team wore earplugs
during the testing. Stimulations were delivered with a Magstim
200 magnetic simulator (Magstim Co Ltd.) with a figure-of-eight
coil (each loop is 70mm in diameter). MEP data were collected
with surface EMG recordings of the APB muscle. Audio feed-
back was examined to assess muscle relaxation of the participant.
Single and paired-pulse TMS was delivered to the hand area of
the contralateral motor cortex with the coil placed tangentially
on the scalp at a 45◦ from the midline. The motor cortex testing
site was ascertained after moving the coil in 1-cm increments to
locate the site producing maximal MEP. The location was marked
for reliable testing throughout the session. The resting MT was
established as the stimulation intensity producing a MEP greater
than 50μV in 5 of 10 TMS pulses with a relaxed muscle. The
suprathreshold test stimulus was obtained but adjusting stimula-
tion intensity to produce a mean MEP 0.5–1.5mV peak-to-peak
in amplitude in the dominant hand muscle. The conditioning
stimulus was set to 80% of the participants resting MT. For SICI
and ICF measures, the conditioning and test stimuli were deliv-
ered to the test site at interstimulus intervals of 2, 4, 10, 15,
20ms in a random, counterbalanced fashion. Each interstimu-
lus interval was tested 12 times and results were averaged. The
left hemisphere was stimulated first in all subjects. For LICI test-
ing, test stimulus intensity was adjusted to reliably produce MEP
0.5–1.5mV peak-to-peak in amplitude in the dominant hand
muscle. For LICI testing the conditioning and test stimuli were
both delivered at this suprathreshold intensity with interstimulus
intervals of 100, 150, and 200ms in a random, counterbalanced
fashion. Each interstimulus interval was tested 10 times and
results were averaged. The MEP data from these paired-pulse
TMS measures was expressed as the percentage of the mean MEP
elicited with the test (unconditioned pulse). For CSP testing, the
participant submaximally (20%) contracted the APB with con-
tralateral single-pulse stimulations at 140% of the participants
resting MT. Ten trials were performed and averaged to deter-
mine the durations of the silent period. The TMS testing was
performed bilaterally for this study providing data from both
hemispheres.
Dependent variables
The outcomes were TMS measures of cortical inhibition (SICI,
LICI, CSP) and excitability (MT, ICF). The TMS measures were
log transformed to obtain a more normal distribution (because of
skewness).
Independent variable and covariates
The primary independent variable was patient age in years. Sex
and CDRS-R total score were included as covariates in the models
to bolster precision in the evaluation of the relationship between
age and each measure of cortical inhibitory or excitatory func-
tioning. Some (Cuypers et al., 2014) but not all (Wasserman,
2002) studies suggest that sex may contribute to variation in
TMSMEP measures. Although, it is not well understood, depres-
sion severity (CDRS-R) may also impact TMS MEP measures
(Croarkin et al., 2013).
STATISTICAL ANALYSIS
This was an exploratory study with the aim of investigating the
impact of age onmeasures of cortical inhibition and excitability in
youth. Analyses were performed on the entire sample and then on
subgroups of healthy and depressed youth. The rationale for this
approach was to maximize limited data and with the realization
that the impact of depression or depression severity on these neu-
rophysiological measures is not definitively known. Demographic
and clinical characteristics for the overall sample of patients and
for depressed youth and healthy controls were described using the
samplemean and standard deviation for continuous variables and
the frequency and percentage for categorical variables. Multiple
linear robust regression (with MM estimation) and the Spearman
partial correlation coefficient (rs) were used to examine the rela-
tionship between age and TMS measures of cortical inhibition
(SICI, LICI, CSP) and excitability (MT, ICF) in the overall sample,
while adjusting for sex andCDRS-R total score, and then separately
in depressed youth and healthy controls, while adjusting for sex.
The estimated slope from the regressionmodel indicates themean
change in each TMS measure per one-year increase in age, while
the sample correlation coefficient indicates not only direction, but
also strength of the linear relationship between age and each TMS
measure. The Spearman partial correlation coefficient can also be
interpreted as the effect size estimator in evaluating themagnitude
of the relationship between age and each TMS measure.
Regression coefficients found to have statistical significance for
each of the two groups in the abovementioned regression analysis,
were then tested in subsequent (post-hoc) regressionmodels (sim-
ilar to that described above) by evaluating the interaction effect of
group (Healthy Controls vs. MDD Patients) with age on the TMS
measure. Comparing the regression parameters (slopes) between
groups was used to assess if the mean change in the TMS mea-
sure per one-year increase in age was different between healthy
controls and MDD patients.
All statistical analyses were performed using SAS software,
version 9.3 (SAS Institute, Inc., Cary, NC, USA). The level of
significance for all tests was set at α = 0.05 (two-tailed). We
implemented the False Discovery Rate procedure (Benjamini and
Hochberg, 1995) to control false-positives over the sets of multi-
ple tests associated with the correlation coefficient and regression
coefficient for the groups of participants (e.g., overall sample,
depressed youth, and healthy controls).
RESULTS
PARTICIPANT CHARACTERISTICS
Twenty-four, medication-naïve participants (14 female) with
MDD completed MT, SICI, ICF, and CSP testing. Demographics
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of the sample are also characterized our prior publication. In
comparing participants with MDD and healthy controls, there
were no statistically significant differences in age, sex, or handed-
ness (Croarkin et al., 2013). These participants were 9–17 years
of age, with a mean [SD] age of 13.8 [2.1] years. The mean
[SD] CDRS-R total score of the MDD youth was 58.9 [8.5] and
the mean [SD] episode duration was 10.9 [9.7] months. Eight
participants with MDD had comorbid anxiety disorders, four
had comorbid attention-deficit/hyperactivity disorder, one had
comorbid oppositional defiant disorder, and one had comorbid
Type I diabetes mellitus. TwoMDD participants were left handed.
Twenty-two healthy controls (11 female) completed MT, SICI,
ICF, and CSP testing. These participants were 9–17 years of age,
with a mean [SD] age of 13.7 [2.2] years. The mean [SD] CDRS-R
total score of the healthy controls was 19.6 [1.6]. Two healthy con-
trols were left handed. Of the 46 adolescents in the current study,
23 (50%) were Caucasian, 13 (28.2%) were African American, 4
(8.7%) were Hispanic, and 13 (28.2%) had a family history of
mood disorder. Family history of mood disorder occurred in 13
of the 24 depressed adolescents (54.2%) and in 0 of the 22 healthy
controls. Fourteen patients with MDD (8 female), with a mean
[SD] age of 14.0 [2.1] years, completed LICI testing. The mean
[SD] CDRS-R total score of these 14 MDD LICI youth was 59.0
[9.6]. Nineteen healthy controls (11 female) with a mean [SD] age
of 13.9 [2.2] years completed LICI testing. The mean [SD] CDRS-
R total score of these 19 healthy control LICI youth was 19.6 [1.7].
Two of these healthy controls who completed LICI testing were
left handed.
AGE AND TMS MEASURES OF CORTICAL INHIBITION AND
EXCITABILITY
In the overall sample of 46 youth, the Spearman partial
correlations and the multiple linear robust regression, while
adjusting for sex and CDRS-R total, revealed a significant neg-
ative linear relationship between age and MT in both the
right (rs = −0.49, raw p = 0.0007, FDR-adjusted p = 0.007;
β = −0.08, 95% CI = −0.12 to −0.05, raw p = 0.0001, FDR-
adjusted p = 0.001) and left (rs = −0.42, raw p = 0.004, FDR-
adjusted p = 0.029; β = −0.05, 95% CI = −0.09 to −0.02, raw
p = 0.0007, FDR-adjusted p = 0.004) hemispheres. This signif-
icant negative relationship of age with MT, while adjusting
for sex, was also observed in the sample of depressed youth
in both the right (rs = −0.70, raw p = 0.0002, FDR-adjusted
p = 0.002; β = −0.09, 95% CI = −0.13 to −0.05, raw p =
0.0001, FDR-adjusted p = 0.001) and left (rs = −0.54, raw p =
0.007, FDR-adjusted p = 0.034; β = −0.05, 95% CI = −0.09
to −0.02, raw p = 0.003, FDR-adjusted p = 0.017) hemispheres,
but not in healthy controls. Note that lower MT values reflect
increased excitability. We also present scatterplots of the log
transformed MT values (left and right hemispheres) against
age, with a fitted regression line and 95% confidence limits,
by depressed youth and healthy controls (Figures 1, 2). We
note that the post-hoc results of the interaction of group with
age indicated that the slope of the regression of MT on age
was similar for both healthy controls and MDD patients in
both the left (p = 0.61; Figure 1) and right (p = 0.28; Figure 2)
hemispheres.
FIGURE 1 | Scatterplots of the log transformed MT values (left
hemisphere) against age, with a fitted regression line and 95%
confidence limits, by healthy controls and MDD patients. Note: The
interaction of group with age indicated that the slope of the regression of
motor threshold on age was similar for both healthy controls and MDD
patients in the left hemisphere (p = 0.61).
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FIGURE 2 | Scatterplots of the log transformed MT values (right
hemisphere) against age, with a fitted regression line and 95%
confidence limits, by healthy controls and MDD patients. Note: The
interaction of group with age indicated that the slope of the regression of
motor threshold on age was similar for both healthy controls and MDD
patients in the right hemisphere (p = 0.28).
Moreover, in the sample of the 33 participants who com-
pleted LICI testing, while adjusting for sex and CDRS-R total,
age had a significant negative relationship with LICI (200ms
interval) in both the right (rs = −0.48, raw p = 0.01, FDR-
adjusted p = 0.056; β = −0.24, 95% CI = −0.39 to −0.09,
raw p = 0.001, FDR-adjusted p = 0.007) and left (rs = −0.64,
raw p = 0.0001, FDR-adjusted p = 0.002; β = −0.23, 95%
CI = −0.32 to −0.14, raw p = 0.0001, FDR-adjusted p = 0.001)
hemispheres. This negative relationship between age and LICI
(200ms interval), while adjusting for sex, was also observed
in depressed participants (Supplementary Table 5) in both
the right (rs = −0.76, raw p = 0.006, FDR-adjusted p = 0.034;
β = −0.35, 95% CI = −0.55 to −0.15, raw p = 0.0007, FDR-
adjusted p = 0.004) and left (rs = −0.92, raw p = 0.0001, FDR-
adjusted p = 0.002; β = −0.25, 95% CI = −0.34 to −0.16, raw
p = 0.0001, FDR-adjusted p = 0.001) hemispheres and in healthy
controls (Supplementary Table 6), but only in the left hemisphere
(rs = −0.45, raw p = 0.05, FDR-adjusted p = 0.877; β = −0.19,
95% CI = −0.36 to −0.02, raw p = 0.02, FDR-adjusted p =
0.478). Note that lower LICI values reflect increased inhibition.
Scatterplots of the log transformed LICI (200ms interval) values
(left and right hemispheres) against age, with a fitted regression
line and 95% confidence limits, by depressed youth and healthy
controls are presented in Figures 3, 4. We note that the post-hoc
results of the interaction of group with age indicated that the
slope of the regression of LICI-200ms on age was similar for
both healthy controls and MDD patients in the left hemisphere
(p = 0.14; Figure 3), but significantly different in the right hemi-
sphere (p = 0.049; Figure 4). A difference in slopes here (in the
right hemisphere) can be interpreted as differences in the mean
change in LICI-200ms per 1-year increase in age between healthy
controls and MDD patients. There were no significant relation-
ships of age with SICI, CSP, or ICF. The correlation and regression
results are presented in Tables 1–6 which are available in the
Supplementary Material. Note that nontransformed data of these
TMS measures from this cohort have been published previously
(Croarkin et al., 2013).
DISCUSSION
This exploratory study builds on prior work examining the
early developmental course of cortical inhibition and excitabil-
ity measures. It is unique in examining these electrophysiological
findings in the context of MDD. As expected, the findings sug-
gest that younger children have high MTs which decrease with
age. Of note, this was statistically significant in the depressed
participant group, but not in the healthy control group. The cur-
rent, developmental MT findings are congruent with prior work
(Eyre et al., 1991). Garvey et al. demonstrated that bilateral MT
measurements decreased with age and in three subjects with a
mean age of 7.6 years (SD 0.5, range 7–7.8) the MT was unob-
tainable with maximum output of the stimulator (Garvey et al.,
2003). Gilbert and colleagues also reported statistically signifi-
cant, negative correlations between age and MT measures from
the left hemisphere in 98 (49 with attention-deficit/hyperactivity
disorder and 49 healthy control subjects) child participants who
were 8–12 years of age (Gilbert et al., 2011). Moll and colleagues
reported similar findings in 40 healthy control subjects who were
8–16 years of age (Moll et al., 1999). The present study is the first
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FIGURE 3 | Scatterplots of the log transformed LICI (200ms interval)
values (left hemisphere) against age, with a fitted regression line and
95% confidence limits, by healthy controls and MDD patients. Note: The
interaction of group with age indicated that the slope of the regression of
LICI-200ms on age was similar for both healthy controls and MDD patients in
the left hemisphere (p = 0.14).
FIGURE 4 | Scatterplots of the log transformed LICI (200ms interval)
values (right hemisphere) against age, with a fitted regression line and
95% confidence limits, by healthy controls and MDD patients. Note: The
interaction of group with age indicated that the slope of the regression of
LICI-200ms on age was significantly different for healthy controls vs. MDD
patients in the right hemisphere (p = 0.049).
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to note this pattern in a group of depressed and healthy control
subject. This finding warrants further consideration and study.
Perhaps, healthy control youth subjects reach an adult MT earlier,
while depressed youth have a more delayed course. It is possible
that differences in scalp to cortex distances could play a role in
these age differences. Recent work demonstrates that brain-scalp
differences are lower in young children and increase throughout
childhood (Beauchamp et al., 2011). Based on this anatomical
finding alone, it might be inferred that lower TMS current would
be sufficient to induce motor activity in younger children and
that younger children would have lower MTs. As this does not
appear to be the case, age related differences are more likely due
to neurodevelopmental changes.
The present CSP, SICI, and ICF findings are inconclusive.
Similarly, findings from two prior studies also found no statis-
tically significant relationships between age and CSP measures
(Garvey et al., 2003; Gilbert et al., 2011). However, Moll and
colleagues reported a correlation with age and CSP in healthy con-
trols which suggests that cortical inhibition and GABAB mediated
neurotransmission is potentiated with age (Moll et al., 1999). It is
often noted that CSPmeasures have large interindividual variabil-
ity in children and adolescents (Garvey and Mall, 2008). Further,
hemispheric differences are also apparent (Garvey, 2008; Garvey
andMall, 2008; Croarkin et al., 2013). In general, our findings and
two prior studies suggest that there are no SICI or ICF age depen-
dent relationships in youth (Garvey et al., 2003; Gilbert et al.,
2011). However, Mall and colleagues examined SICI in 50 healthy
participants aged 6–34 years. In this case, children and adolescents
had less SICI as compared to adults, which suggests that corti-
cal inhibition and GABAA mediated neurotransmission develops
throughout childhood (Mall et al., 2004). This effort did involve
stimulation with a round rather than a figure-of-eight coil but
otherwise its methodology was congruent with negative studies.
The current findings suggest that LICI inhibition increases
with age youth. In particular, LICI (200ms interval) had a sta-
tistically significant negative relationship with age in depressed
youth, but not in healthy control participants. It is important
to acknowledge the lack of a relationship may be attributable
to low power, given the high degree of variability in the mea-
sure in general. Lower LICI ratios signify greater inhibition and
increased GABAB mediated neurotransmission (Connors et al.,
1988; McDonnell et al., 2006; Daskalakis et al., 2008). Prior
work postulates that deficits in GABAA and GABAB mediated
neurotransmission play a role in the pathophysiology of MDD
(Bajbouj et al., 2006; Levinson et al., 2010; Croarkin et al., 2011).
However, GABAB receptors are widely distributed throughout
the brain presynaptically and postsynaptically with complex and
diverse functioning (Benarroch, 2012). In some instances, facili-
tated GABA activity likely contributes to neuropsychiatric disease
mechanisms. Heightened thalamic postsynaptic GABAB activity
is thought to play a central role in the pathophysiology of petit
mal seizures (Blumenfeld andMcCormick, 2000;McCormick and
Contreras, 2001). Other work suggests that that aberrant interplay
between GABA and NMDA receptors is necessary for the genesis
of hippocampal seizures (Bradford, 1995; Katsumori et al., 1998).
Enhanced GABAB development in childhood could represent a
vulnerability to or a consequence ofmood disorders. Our findings
are unique in that there are no other known published reports
examining potential relationships of age with LICI measures in
child and adolescent samples.
Longitudinal studies of cortical inhibition and excitability dur-
ing childhood are warranted. The GABAergic and glutamatergic
neurotransmitter systems have a complex and poorly understood
maturation with which widely influences central nervous sys-
tem development and functioning. For example, in prenatal and
early infantile life GABA serves as an excitatory neurotransmit-
ter and this is mediated primarily by the structure and fuction
of GABA receptors (Ben-Ari et al., 1994; Leinekugel et al., 1999;
Rakhade and Jensen, 2009). It is thought that density of GABAA
receptors decreases from childhood to adulthood (Chugani et al.,
2001) and that the subunit composition of GABAA receptors
varies substantially during development (Duncan et al., 2010).
Lower cortical inhibition early in life may reflect increased plas-
ticity and optimum conditions for learning and development
(Mall et al., 2004). Safe, noninvasive, in vivomeasures afforded by
TMS offer an important tool to probe the development of these
neurotransmitter systems (Dayan et al., 2013).
LIMITATIONS
These discussion points and findings must be placed in the con-
text of the limitations of the study. This was a post-hoc exploratory
study, which was based on a small, age-restricted, sample. The
parent study (Croarkin et al., 2013, 2014) from which the cur-
rent findings are based was not designed to specifically address
the question of age effects on TMS measures of cortical inhi-
bition and excitability. Like previous studies that examined the
effects of age on TMS measures, the current study design was
cross-sectional. A longitudinal study would provide more insight
into the pattern of findings regarding the impact of development
over the lifespan. It is also unknown if alterations in cortical inhi-
bition and excitability measures are deficiencies related to the
burden of psychiatric illnesses or markers of risk. Moreover, a
cross-sectional approach is limited as it has been demonstrated
that TMS measures have wide inter-individual variability (Kiers
et al., 1993; Cuypers et al., 2014). The present findings may relate
to the ontogeny of GABA and glutamate neurotransmission or
could be a result of developmental changes in anatomy, such as
skull bone shape and thickness.
CONCLUSIONS
These findings provide additional information regarding the
potential impact of age on TMS measures of cortical excitabil-
ity and inhibition. Findings suggest that younger children have
higher MTs which decrease with age and that this is more pro-
nounced in depressed youth. These findings also suggest that LICI
inhibition may increase with age and, like MTs, this is more pro-
nounced in depressed youth. Present CSP, SICI, and ICF findings
are inconclusive and warrant further study.
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